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ABSTRACT An interleukin 1a (IL-1a) cDNA probe and an
IL-l responsive T-cell clone (D1O.G4; half-maximal stimulation,
0.1-1 pM) have been used to study the production of IL-1 by
primary murine cell populations, particularly macrophages and
dendritic cells. Spleen and peritoneal macrophages produced IL-1
mRNA and released biologically active IL-1 when challenged with
lipopolysaccharide (LPS). Induction of IL-1 was evident over a
dose range of 0.01-10 ,jg of LPS per ml, and maxmal mRNA
levels were maintained from 4 to 20 hr. Several other stimuli did
not induce IL-1 in cultured macrophages, including phorbol
12-myristate 13-acetate, r-interferon, Con A, macrophage colo-
ny-stimulating factor, IL-3, cachectin, and activated T cells.
Activated T cells could markedly reduce the response ofperitoneal
macrophages to LPS. When other cell types were compared with
macrophages, keratinocytes had high levels of IL-1 mRNA,
apparently in response to endogenous LPS. However B and T
lymphocytes did not yield detectable IL-1 during proliferative
responses to LPS and Con A, respectively, While dendritic cells
produced little or no IL-1 when challenged with a battery of
stimuli. Therefore, IL-1 may not be required for the potent
accessory function of dendritic cells in lymphocyte mitogenesis.
The results indicate that macrophages and dendritic cells have
different secretory capacities. The macrophage is the principal
leukocyte that synthesizes IL-1, and select stimuli increase and
decrease the levels of macrophage IL-1 mRNA.
Interleukin 1 (IL-1) is a 16-kDa polypeptide that mediates
several aspects of acute and chronic inflammation (1). The
events that are influenced by IL-1 include synthesis of acute
phase proteins by hepatocytes, release of degradative en-
zymes from connective tissue cells, and proliferation of
lymphocytes (1). Among the leukocytes, macrophages, lym-
phocytes, and dendritic cells have all been implicated in
production of IL-1 (2-8).
RNA blotting and a sensitive IL-1 bioassay have recently
become available to study the production of IL-1. We have
used these assays on primary cell populations with an
emphasis on a comparison of macrophages and dendritic
cells. These leukocytes have different roles in cell-mediated
immunity. The macrophage functions as an effector cell in
phagocytosis and anti-microbial resistance, while the
nonphagocytic dendritic cell acts as a potent, if not essential,
accessory cell for induction of antigen-specific sensitized T
lymphocytes (9-11). The capacity of these two cell types to
synthesize cytokines such as IL-1 has not been compared in
detail. We report that macrophages, but not dendritic cells,
make IL-1, and we define some of the stimuli that increase
and decrease the levels of macrophage IL-1 mRNA.
MATERIALS AND METHODS
Mice. BALB/c X DBA/2 (C x D2)F1, B6.H-2k, ICR,
C3H/He (The Trudeau Institute, Saranac Lake, NY), and
BALB/cAnN (The Rockefeller University) mice of both
sexes were used with similar results.
Medium. RPMI 1640 medium (GIBCO) was supplemented
with 10% heat-inactivated fetal calf serum (Sterile Systems,
Logan, UT)/1 mM glutamine/streptomycin (10 ,ug/ml)/pen-
icillin (100 units/ml)/gentamycin (20 gg/ml)/50 ,4M 2-mer-
captoethanol.
Cytokines. Murine recombinant IL-1,a (rIL-la) [specific
activity, 6 x 106 units/mg in the standard thymocyte
mitogenesis assay (12)] was provided by P. Lomedico (Hoff-
mann-La Roche). Murine recombinant y-interferon (rIFN-y)
(6 x 106 units/mg) was provided by Genentech (South San
Francisco, CA), and human recombinant cachectin/tumnor
necrosis factor (108 units/mg) was from B. Beutler and A.
Cerami (The Rockefeller University). Conditioned media
from the'WEHI-3 cell line and L cells were used as sources
of IL-3 and macrophage colony-stimulating factor, respec-
tively.
Lipopolysaccharide (LPS). Boivin preparations of Esche-
richia coli 05:B55 and Salmonella typhosa LPS were from
Difco. Purified LPS from E. coli K-12, rough mutant 94 mm,
was from List Biological Labs (Campbell, CA).
IL-1 Bioassay. The D10.G4.1 T cell clone was passaged as
described (13). A standard curve was constructed relating
D10 growth to rIL-1 dose (units determined in the thymocyte
assay). This curve was related to the dose-response curve of
various samples. Half-maximal stimulation of D10 cell
growth was observed at 0.01-0.1 unit of rIL-la per ml (0.1-1
pM) or 0.3% (vol/vol) LPS-stimulated macrophage culture
supernatant.
Phenol/Chloroform Extraction (14) of Cytoplasmic RNA.
Cells in suspension were washed in Hanks' balanced salt
solution without Ca2+ or Mg2+. Adherent cells were rinsed in
RPMI 1640 medium and dislodged with a cell scraper (Costar,
Cambridge, MA) in Hanks' balanced salt solution. After
centrifugation, cells were resuspended in 1 ml ofTSM buffer
(0.14 M NaCl/10 mM Tris HCl, pH 8.6/1.5 mM MgCl2) plus
5% vanadyl ribosyl complex (VRC, New England Biolabs)
and centrifuged for 3 min at 1500 x g. The pellet was
resuspended in 3-4 vol of lysis buffer (TSM/0.5% Nonidet
P-40/10% VRC), mixed in a Vortex, set on ice for 3 min, and
nuclei were removed by centrifugation of 2000 x g for 4 min.
The cytoplasmic supernatant was added to an equal vol of
proteinase K (200 ,ug/ml) (Merck) in 0.2 M Tris'HCl, pH
7.5/25 mM EDTA/0.3 M NaCl, and incubated at 37°C for 30
min. RNA was extracted twice with an equal vol of
Abbreviations: LPS, lipopolysaccharide; PMA, phorbol 12-myris-
tate 13-acetate; IFN, interferon; rIFn, recombinant IFN; IL-1 and -3,
interleukins 1 and 3; EA, erythrocytes coated with antibody.
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FIG. 1. LPS induction of IL-1 mRNA in peritoneal macrophages.
(A) Kinetics of the response in thioglycollate macrophages and
spleen B cells. Cells were cultured with or without LPS (10 ,ug/ml)
for 0, 4, 20, 48, and 72 hr. The B-cell proliferative response was
130,000 cpm per 3 x 105 cells after an 8-hr pulse of [3H]thymidine (4
,uCi/ml; 1 Ci = 37 GBq) on day 3. RNA (5 .tg) (yield per 107 cells)
was electrophoresed and hybridized with p1301 IL-1a cDNA. The
blots were exposed for 2 days. For the lane with IL-1 mRNA on the
far right, we applied 0.25 jig of RNA from the J774 mouse macro-
phage cell line stimulated with LPS for 6 hr. (B) Dose response oftwo
LPS preparations. Dot blots were prepared using 5 ,jg (rows A and
C) and 0.5 ,g (rows B and D) samples of RNA from thioglycollate-
elicited macrophages that had been cultured for 20 hr with graded
doses of LPS from S. typhosa (rows A and B) and E. coli K-12 (rows
C and D).
Table 1. Kinetics of IL-1 release from LPS-induced
macrophages and lymphocytes
Time in IL-1 activity, units/ml
culture, Macrophages Macrophages T cells B cells
hr - LPS + LPS + LPS + LPS
4 0.35 0.95 0.001* <0.001*
20 0.66 44.8 0.001* <0.001*
48 0.47 38.2 0.002* 0.001*
72 0.44 32.4 0.004* 0.001*
Thioglycollate-elicited peritoneal macrophages, T cells, or B
lymphocytes (106) were cultured in 1 ml of medium in 16-mm
diameter wells with or without LPS (10 Ag/ml). Graded doses of
culture supernatant were assayed for activity in the D10 bioassay
(see Fig. 4 for standard curves and assay conditions).
*Sample in which the IL-1 level was less than half-maximal (-0.01
unit of rIL-1 per ml) at 10% (vol/vol).
per Ag of DNA. Blots were hybridized overnight with 106
cpm/ml and washed as described (15). Filters were exposed
2-5 days to Fuji film with intensifying screens. To visualize
actin mRNA on the IL-1 blots, we stripped the latter with 5
mM Tris HCl, pH 8.0/0.002% polyvinylpyrrolidone (40
kDa)/0.002% bovine serum albumin/0.002% Ficoll (400 kDa)
for 2 hr at 70TC, and then hybridized with the actin probe.
Cells. Low-density spleen adherent populations were sep-
arated into dendritic cells (Fc receptor negative) and macro-
phage (Fc receptor positive)-enriched populations using
erythrocytes coated with antibody (EA; see ref. 17). The EA-
cells were >95% dendritic cells and <3% B cells and
macrophages, while EA' cells had equal percentages of
macrophages and B lymphocytes and <10% dendritic cells.
Erythrocytes were lysed with 0.83% NH4Cl. Peritoneal
macrophages were obtained by adhering 3 x 107 resident or
107 elicited (1 ml of Brewer's thioglycollate, Difco, 5 days
earlier) peritoneal cells on 100-mm plastic culture dishes. At
2 hr, nonadherent cells were removed by washing. B cells
were Sephadex G-10 nonadherent spleen lymphocytes that
were treated with anti-thy-i, lyt-1, lyt-2 monoclonal antibody
and complement (clones HO 13.4, C3PO, and HO 2.2 from
the American Type Culture Collection). B cells were cultured
at 1 and 3 x 106 cells per ml to test for IL-1 release and
mRNA, respectively. Keratinocyte monolayers were ob-
tained from mouse epidermal suspensions (18). The trace
epidermal Langerhans cell component was nonadherent (18).
T lymphocytes were nylon wool nonadherent spleen and
lymph node suspensions treated with anti-Ia (B21-2, Amer-
ican Type Culture Collection, no. TIB 229) and rabbit
complement (Pel-Freez).
preequilibrated phenol/chloroform (1:1) and once with
chloroform/isoamyl alcohol (24:1). RNA was precipitated
with 2.5 vol of 100% ethanol overnight at -20°C, pelleted by
centrifuging at 12,000 x g for 10 min, resuspended in water,
and stored at -20°C. RNA yields were 0.3-2.0 jig per 106
cells as determined by absorbance at 260 nm. RNA quality
was assessed by A260/A280 ratios and by electrophoresis in
ethidium bromide/agarose gels to compare 28S and 18S
ribosomal RNA bands.
RNA Blots. Samples were quantitated by A280 and RNA
blot analyses were performed as described (15) using
GeneScreen filters (New England Nuclear). For dot blots,
samples were adjusted to 3x SSC (lx SSC = 0.15 M
NaCl/0.015 M sodium citrate)/7.4% formaldehyde, heated to
60°C for 5 min, applied to filters with a dotting manifold
(Bio-Rad), and processed as described above. p1301 IL-iS
cDNA plasmid (12) (provided by P. Lomedico) and a chicken
actin probe (16) were labeled with [32P]dCTP (New England
Nuclear) using a nick-translation reagent kit (Bethesda Re-
search Laboratories). Specific activities were 2-4 x 107 cpm
RESULTS
IL-1 Production by LPS-Stimulated Macrophages. Perito-
neal macrophages could transiently (<16 hr) express some
IL-1,, mRNA upon isolation, so that cells were cultured
overnight before use in most experiments. The 24-hr cultures
expressed little or no IL-1 mRNA but were induced with LPS
(Fig. LA Left). The mRNA was a single 2.6-kilobase (22S)
message that comigrated with the IL-1a mRNA from the
LPS-induced macrophage cell line J774. mRNA was detect-
able at 1 hr (not shown), maintained plateau levels for 4-20
hr, and decreased markedly by 48 hr (Fig. LA). LPS from S.
typhosa and purified LPS from an E. coli strain K-12 rough
mutant had comparable IL-1 inducing activity with plateau
levels ofmRNA at 10 ng/ml (Fig. 1B). Polymyxin B, a cyclic
peptide that binds and neutralizes LPS, reduced the IL-1-
inducing activity of LPS -100-fold but did not alter macro-
phage viability, total RNA yield, or actin mRNA levels (not
shown).
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FIG. 2. LPS is the principal inducer of IL-1 in macrophages. (A) Response of thioglycollate-elicited macrophages to the indicated stimuli.
Macrophages (107) were cultured for 20 hr with single or multiple stimuli. The doses were LPS (10 jig/ml), phytohemagglutinin (PHA) (2 ,ug/ml)
(Burroughs Wellcome, Research Triangle Park, NC), IFN-,y (100 units/ml) (Genentech, South San Francisco, CA), PMA (10 ng/ml) (Sigma),
Con A (3 jg/ml) (Pharmacia). Top row, 5; bottom row, 0.5 ,ug of RNA blotted sequentially for IL-1 and actin mRNAs. The amounts of IL-1
activity in the culture medium (units/ml in the D10 bioassay) are listed in parentheses for each stimulus; 0.01 unit of rIL-1a per ml is a
half-maximal stimulus for the D10 bioassay (see Fig. 4A). (B) Lack of IL-1 in macrophage-T-cell cocultures. Peritoneal adherent cells (3 x 106)
were cultured for the indicated times with LPS (10 ttg/ml) (left) or with 3 x 107 purified T cells plus Con A (3 ,ug/ml) (right). For each lane,
RNA was separately extracted from the macrophage-rich adherent fraction (shown) and nonadherent cells (T cells plus some macrophages; only
the 48-hr time point is shown on the far right). [3H]Thymidine uptake of 300,000 T cells plus 30,000 macrophages was 43,000 cpm (exposure,
4 ,uCi/ml at 48-60 hr). (C) Lack of IL-1 in macrophages cultured with IFN-y or with alloreactive T lymphoblasts. Thioglycollate-elicited
macrophages (1.2 x 107) from B6.H-2k mice were cultured 3 days with or without IFN-y (10 units/ml) to induce Ia antigens. Lyt-2- alloreactive
T blasts (C x D2 anti-B6.H-2k; ref. 10) were added for 18 hr at a T-cell/macrophage ratio of 1:1 (middle four lanes) or 1:10 (right four lanes).
[3H]Thymidine uptake of 30,000 T blasts plus 10,000 macrophages was 98,000 cpm after exposure to 4 MCi/ml at 24-32 hr. When present, the
LPS dose was 10 ,ug/ml. RNA was extracted from the adherent (shown) and nonadherent (not shown, but IL-1 mRNA was not detectable) layers
and 5 ,ug of RNA was loaded per lane.
LPS stimulated B cells to proliferate actively but did not
induce IL-l1a mRNA (Fig. 1A Right). The finding was
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confirmed with the D10 bioassay, which showed that mac-
rophages released high levels of IL-1, while B and T cell
populations were essentially inactive (Table 1). Whereas
IL-1a mRNA reached plateau levels 4 hr after addition ofLPS
to macrophages (Fig. 1A), the cytokine was just detectable in
the medium at that time (Table 1).
Comparison of LPS with Other Stimuli. A large number of
agents have been considered to be active in inducing IL-1 (1).
Many proved to be weak or inactive when tested on primary
peritoneal (Fig. 2) and spleen (see below) macrophages. The
stimuli included Con A, phorbol 12-myristate 13-acetate
(PMA), and IFN-y either alone or in combination (Fig. 2A).
Phytohemagglutinin induced -1/10th the level of IL-1 as
LPS, but we could not rule out contamination of the
phytohemagglutinin with some LPS. None of the stimuli
synergized with LPS. Resident and thioglycollate-elicited
macrophages behaved similarly (not shown).
Several approaches were taken to test whether T cells
could induce IL-1 from macrophages, but none were effec-
tive. These included T cells added to macrophages in the
presence of Con A (Fig. 2B), the conditioned medium from
Con A-stimulated rat spleen cells (data not shown) and
rIFN-y (Fig. 2C), and alloreactive T lymphoblasts (Fig. 2C).
In the macrophage-T-cell coculture experiments (Fig. 2 B
and C), we observed clustering of the two cell types and
significant T-cell proliferation (Fig. 2, legend) but little or no
IL-1 mRNA. Remarkably, the addition of alloreactive T
blasts reduced the level of IL-1 mRNA in response to LPS but
had no effect on cell viability or actin mRNA levels (Fig. 2C).
FIG. 3. Spleen macrophages but not dendritic cells, make IL-1
mRNA. Spleen low-density adherent cells (SAC) were cultured 20 hr
with LPS (10 ,g/ml), PMA (10 ng/ml), or LPS plus phytohemag-
glutinin or IFN-y. RNA was extracted from unfractionated SAC, or
from dendritic cell (DC)-enriched and macrophage-B-cell-enriched
(Mo) components ofSAC prepared by a one-step rosetting technique
(17). RNA from the J774 cell line (1 ,tg) or RNA from the primary
cells (3 tkg) was loaded on the lanes. This experiment was performed
three times with similar results.
1--mbwmb.ml
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FIG. 4. Spleen macrophages but not dendritic cells release IL-1 biologic activity. Data are means of triplicate cultures of 2 x 104 D10 cells
exposed to graded doses of conditioned medium and exposed to [3H]thymidine at 48-62 hr (18). As in Fig. 3, Fc receptor positive and negative
fractions were prepared by a one-step resetting method. (A) Dose response of rIL-1 (a) vs. E. coli control (nu) (no IL-1 DNA insert) protein in
inducing the proliferation ofD10 cells. (B) Release ofIL-1 from Fc receptor positive spleen adherent cells following culture with a panel of stimuli:
*, 10 Ag of LPS per ml; r, 100 units of IFN-y per ml; A, 1 ng of cachectin/tumor necrosis factor per ml; o, 30o (vol/vol) WEHI-3 conditioned
medium; A, 30%o (vol/vol) L-cell conditioned medium; 0, 10 ng of PMA per ml; o, no stimulus. The small effect seen with PMA is also evident
in the medium control (see D). (C) Lack of IL-1 release from stimulated Fc receptor negative dendritic cells. (D) Medium control-i.e., wells
cultured with the stimuli but in the absence of cells.
We did not assay the macrophage-T-cell medium for IL-1
biologic activity, since the D10 cell line would respond to the
IL-2 that was released by the stimulated lymphocytes. We
conclude that LPS is the principal agent that induces IL-1 in
mouse peritoneal macrophages, while sensitized T cells can
reduce the LPS effect.
Comparison of Spleen Macrophages and Spleen Dendritic
Cells. Adherent spleen cells contain Fc receptor negative
dendritic cells and Fc receptor positive macrophages and B
lymphocytes. The former induce T-cell responses to several
antigens in vitro and in vivo (9-11, 19). Spleen adherent cells,
like peritoneal cells, could be induced to express IL-1 mRNA
by LPS (Fig. 3). When the populations were separated into
dendritic cells and macrophage-B-cell-enriched fractions
CD2 C3H/HEJ







FIG. 5. Expression of IL-1 mRNA in keratinocytes. Keratino-
cyte monolayers were cultured for 48 hr with or without exogenous
LPS (10 ,ug/ml). The cells were from LPS responsive (C x D2)F1 and
nonresponsive (C3H/HeJ) mice. RNA was extracted, and 5 jg was
electrophoresed and probed for IL-1 and actin mRNAs.
after LPS stimulation, the latter synthesized IL-1 mRNA
(Fig. 3). The trace amount of IL-1a mRNA in the Fc receptor
negative dendritic cell-enriched fraction could be attributed
to residual macrophages (<3% ofthe total cells). Since spleen
B cells did not produce IL-1 (Fig. 1, Table 1), the active Fc
receptor positive cell was likely the macrophage.
The dendritic cell- and macrophage-enriched fractions of
spleen-adherent cells were stimulated with a variety of
individual cytokines, PMA, or LPS. When the conditioned
medium was tested for IL-1 in the sensitive D10 bioassay,
only macrophages released active IL-1 when exposed to LPS
but not other stimuli (Fig. 4). Dendritic cells did not release
IL-1 (Fig. 4), and frozen-thawed lysates of dendritic cells
lacked activity (not shown). When unfractionated adherent
cells were treated with monoclonal antibody 33D1 and
complement to deplete dendritic cells (9), the production of
IL-1 in response to LPS was not reduced (not shown). Thus,
IL-1 primarily is a macrophage rather than a dendritic cell
product.
IL-1 mRNA Expression in Keratinocytes. Epidermal cells
release a cytokine that is similar to IL-1 (20). Keratinocyte
monolayers that were depleted of Ia positive dendritic cells
were prepared (18) and analyzed for IL-1a mRNA. Keratin-
ocytes from (C x D2)F1 mice had significant levels of IL-1
mRNA. The amounts increased slightly upon addition of
LPS. Since exposure to LPS (from the Gram-negative bac-
teria in mouse skin) during the preparation of epidermal cell
suspensions was likely, we asked if cells from LPS unre-
sponsive C3H/HeJ mice also had IL-1. None was found, and
no response to LPS was observed (Fig. 5). Thus, the
expression of IL-1 mRNA in primary mouse keratinocytes is
likely a response to LPS.
DISCUSSION
Prior work on the functional properties of dendritic cells has
revealed a lack of phagocytic function but an important
accessory role in initiating cell-mediated immunity (reviewed
in ref. 19). Little is known about dendritic cell secretory
function, particularly with respect to cytokines, the polypep-
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immunity. The recent isolation of IL-1 cDNA clones and the
IL-1 responsive D1O.G4 cell line allows one to follow the
production of IL-1 with a specificity and sensitivity that was
not previously possible. Using RNA blotting and the D10
bioassay on primary cells, we detect little or no IL-1
production by dendritic cells (Figs. 3 and 4). Since IL-1 is not
produced by neutrophils (21) or proliferating B and T lym-
phocytes (Figs. 1 and 2; Table 1), it seems that the macro-
phage is the principal leukocyte that makes IL-1.
The stimuli for macrophage IL-1 gene expression seem
quite restricted, however. LPS is such a potent inducer (Fig.
1B) that the presence of small numbers of macrophages or
small amounts of LPS severely complicates the analysis of
IL-1 inducing stimuli and responsive primary cells. Con A,
PMA, macrophage colony-stimulating factor, IL-3, IFN-y,
cachectin, and T cells do not trigger spleen and peritoneal
macrophages (Figs. 2 and 4). Since we have only studied
cultured tissue macrophages, some ofthe inactive agents may
stimulate other populations of mononuclear phagocytes such
as the blood monocyte. We also note little or no IL-1 mRNA
(experiments not shown) in peritoneal macrophages elicited
by periodate, thioglycollate, or bacillus Calmette-Gudrin
mycobacteria in situ (at day 5, the height of the inflammatory
response).
The effect of T cells on the induction of IL-1 is under
further study. A subpopulation of T cells, or a particular
developmental stage of the macrophage such as the blood
monocyte, may be required to observe IL-1 induction. This
possibility is being pursued with human blood monocytes and
a rabbit anti-IL-i antibody to identify individual monocytes
with IL-1 (22). The mixing of sensitized T cells with macro-
phages can clearly reduce IL-1ia mRNA (Fig. 2C). It remains
to be determined whether this inhibition is due to a soluble
T-cell factor.
Our results question the need for IL-1 in lymphocyte
activation. B cells proliferating in response to LPS, and T
lymphocytes proliferating in association with macrophages,
do not necessarily produce the cytokine (Figs. iA and 2B and
C). Dendritic cells, which are active accessory cells for a
variety ofT-dependent immune responses (9-11), also do not
appear to make IL-1 (Figs. 3 and 4). Exogenous rIL-i has
little direct effect on T cells even in the presence of lectin or
antigen (13). Therefore, IL-1 may not be essential for lym-
phocyte mitogenesis. Recent experiments indicate that IL-1
amplifies the capacity of dendritic cells to stimulate T cells
(13). This amplification may account for some ofthe previous
observations on the lymphocyte-activating properties of this
cytokine.
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